甲状腺功能低下症中便秘的综合管理:评估药理和非药理干预措施
Eman M Gaber Hassan1,2, Sharell Lewis1, Sajedah Fawzi Alsadiq3
1Department of Nursing, Mohammed Al-Mana College for Medical Sciences, Dammam 34222, Saudi Arabia.
Nursing reports (Pavia, Italy)
|October 28, 2025
概括
甲状腺功能低下症患者经常经历便秘. 虽然他们意识到这种联系,但他们的知识是有限的. 生活方式的改变,如增加水和纤维摄入量,被认为是有效的管理策略.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 慢性便秘是一种普遍的胃肠道疾病,具有多种病因,包括甲状腺功能低下症.
- 它显著影响患者的生活质量,需要量身定制的管理.
- 了解患者对低甲状腺症便秘管理的看法至关重要.
研究的目的:
- 调查关于甲状腺功能低下症患者便秘的知识和实践.
- 评估这种人群中药理和非药理干预措施对便秘的感知有效性.
主要方法:
- 从2025年1月到5月进行了一项描述性的横截面研究.
- 从300名甲状腺功能低下症患者中收集了数据,使用了肠道习惯问卷.
- 参与者是从沙特阿拉伯的一家私人医院招募的.
主要成果:
- 参与者承认甲状腺功能低下是导致便秘的原因,但报告具体知识有限.
- 药理和非药理方法,特别是增加水分,纤维和运动,通常使用并被认为是有效的.
- 便秘的频率与年龄,疾病持续时间和管理策略的使用相关.
结论:
- 年龄,甲状腺功能低下的持续时间和管理策略显著影响受影响患者的便秘.
- 诸如充足的水分和纤维摄入等非药理方法是非常有效的.
- 护士应该解决知识差距,并将肠道健康教育纳入护理计划,以改善自我管理和结果.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
698
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
698
Irritable Bowel Syndrome III: Medical and Nursing Management
638
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
638
Drugs for Treatment of Diarrhea-Predominant IBS
618
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
618
Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
523
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
523
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631


